Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome.
about
Hepcidin antagonists for potential treatments of disorders with hepcidin excess.Extravascular lung water correlates multiorgan dysfunction syndrome and mortality in sepsis.NOX2 protects against progressive lung injury and multiple organ dysfunction syndrome.Regulatory T cells are protective in systemic inflammation response syndrome induced by zymosan in miceProtective effect of Flt3L on organ structure during advanced multiorgan dysfunction syndrome in mice.Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo.Spontaneous inflammatory pain model from a mouse line with N-ethyl-N-nitrosourea mutagenesis.Lipopolysaccharide-induced endotoxemia in corn oil-preloaded mice causes an extended course of lung injury and repair and pulmonary fibrosis: A translational mouse model of acute respiratory distress syndrome.HMGB1 Inhibition During Zymosan-Induced Inflammation: The Potential Therapeutic Action of RiboflavinBeneficial effect of a CXCR4 agonist in murine models of systemic inflammationCombination therapy of molecular hydrogen and hyperoxia improves survival rate and organ damage in a zymosan-induced generalized inflammation model.Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes.Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490.Dectin-1 plays a redundant role in the immunomodulatory activities of β-glucan-rich ligands in vivo.Subanesthetic isoflurane relieves zymosan-induced neutrophil inflammatory response by targeting NMDA glutamate receptor and Toll-like receptor 2 signalingRelative antioxidant activities of quercetin and its structurally related substances and their effects on NF-κB/CRE/AP-1 signaling in murine macrophages.Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models.Crosstalk between complement and toll-like receptors.Murine Models of Sepsis and Trauma: Can We Bridge the Gap?Mast cells mediate early neutrophil recruitment and exhibit anti-inflammatory properties via the formyl peptide receptor 2/lipoxin A4 receptor.PD-L1 blockade improves immune dysfunction of spleen dendritic cells and T-cells in zymosan-induced multiple organs dysfunction syndromesThe transcriptional activation of the cyclooxygenase-2 gene in zymosan-activated macrophages is dependent on NF-kappa B, C/EBP, AP-1, and CRE sites.Zymosan-Induced Peritonitis: Effects on Cardiac Function, Temperature Regulation, Translocation of Bacteria, and Role of Dectin-1.Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice studyHeme-Exposed Pooled Therapeutic IgG Improves Endotoxemia Survival.Prostaglandins mediate zymosan-induced sickness behavior in mice.Melanocortins protect against multiple organ dysfunction syndrome in miceRole of biphasic changes in splenic dendritic cell activity in a mouse model of multiple organ dysfunction syndrome.Percutaneous toxicity of dinitrochlorobenzene (DNCB) in rats.T cell activation status determines the cytokine pattern induced by zymosan and bacterial DNA both in thymocytes and splenocytes.N-acetylcysteine administration is associated with reduced activation of NF-kB and preserves lung dendritic cells function in a zymosan-induced generalized inflammation model.The role of Syk/IĸB-α/NF-ĸB pathway activation in the reversal effect of BAY 61-3606, a selective Syk inhibitor, on hypotension and inflammation in a rat model of zymosan-induced non-septic shock.Evodiamine Inhibits Zymosan-Induced Inflammation In Vitro and In Vivo: Inactivation of NF-κB by Inhibiting IκBα Phosphorylation.Activation of α7 Nicotinic Acetylcholine Receptor Ameliorates Zymosan-Induced Acute Kidney Injury in BALB/c Mice
P2860
Q33563777-0D20969B-4294-4241-B9D4-E69F636DA0B9Q33780947-26622101-9015-4875-A732-BC37F422B254Q33840366-CEE27807-0263-428B-ADD7-B11869739119Q34723343-093A2EE0-5D70-4EB7-A387-DCFF6D385D3EQ35535334-0EBFDA0A-7F2E-4E59-80DA-762BBB705184Q35850677-80229048-A176-49B7-BD3F-180B72B38D33Q36150477-4C048DC5-1BF1-4F74-BD8E-ECD200B1FD48Q36319867-6F567C18-91C3-4BDD-9338-C95C358E4BF1Q36723856-9F425A51-286E-4B61-B47A-9F19F4BA5E31Q36730776-1538B3F0-59CC-4D97-BD26-273D64C63EE3Q36953310-E726A615-7EEC-4006-8CBE-5AA03AC33746Q37170492-A081B837-3583-4E2A-9421-73A76C5C5E3BQ37204775-2EB04D2E-AA3D-4982-AD8C-6F5069F8A021Q37339857-7181EB29-819E-439F-B499-64D2AB7718E9Q37362514-48220321-D842-4D4D-A80B-1257DBBA462CQ37462184-F4C749BD-A78A-4DED-93E5-6D436E50BBE8Q37738313-F26D1109-DD70-4FB6-B156-21387FE88A55Q37959890-81C23380-2918-4A14-86F2-C92FE3AD2C1EQ38690754-E22CDB42-5096-471C-9C04-7779468E093BQ38804946-D46EDB4D-DC43-4B7D-9216-184E5B73CC51Q39614582-3C732DBC-F1C0-4A04-A54B-C70CC1C2975DQ39628265-E4FB40AD-4162-4098-A0DA-943A7EA0B268Q39630006-B953E8C2-CABF-4266-B73D-D4BF00B5AB6DQ39767528-52AFA539-8F6B-4927-83FD-38E6B80CE996Q40474979-9648EE19-87D7-41CD-B55D-7FE8F56C6A30Q40517801-FBCDEA51-C493-40FA-AE1E-3022DC945526Q42618304-07CE64CB-E86C-40CF-8271-98C84DEDE545Q42660401-A9EAC22F-640A-4B81-94A9-3F257CA05ACAQ43883976-C1B3DE8E-E043-43F5-B0B2-758DA9CBA18FQ44048514-31934660-38B5-4CDA-BA32-1D1A8858E689Q44203626-54BFE443-6AA3-4FD0-BBB4-AEBA9ECF61DAQ48287536-9A3E34FA-E81F-483C-85BB-24D5A1A64555Q51088688-A706590F-3903-4CDC-8E23-61E87AC31BD2Q59127028-665246CC-BF8A-4BD5-A297-81CF3FFC2D9F
P2860
Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Zymosan-induced generalized in ...... le organ dysfunction syndrome.
@ast
Zymosan-induced generalized in ...... le organ dysfunction syndrome.
@en
type
label
Zymosan-induced generalized in ...... le organ dysfunction syndrome.
@ast
Zymosan-induced generalized in ...... le organ dysfunction syndrome.
@en
prefLabel
Zymosan-induced generalized in ...... le organ dysfunction syndrome.
@ast
Zymosan-induced generalized in ...... le organ dysfunction syndrome.
@en
P2093
P1433
P1476
Zymosan-induced generalized in ...... le organ dysfunction syndrome.
@en
P2093
R Jan A Goris
Thijs Hendriks
Thomas J H Volman
P304
P356
10.1097/01.SHK.0000155350.95435.28
P577
2005-04-01T00:00:00Z